Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
Twitter Feed
-
Register for the #Immunologysummit2021 TODAY to discover the Summit agenda. Be sure to choose your topic of interest upon registration!
— UCB News (@ucb_news) 16.04.2021 -
BREAKING NEWS! The agenda for the #ImmunologySummit2021 has now been released. Click the link below to register for the Summit and find out more about the learning experiences that will be offered on 25th & 26th June.
— UCB News (@ucb_news) 14.04.2021 -
We’re proud to support World Parkinson’s Day joining people living with Parkinson's, supporters, fundraisers and families, carers and clinicians, to come together and tell their story. To find out more about our work and latest research, visit https:/
— UCB News (@ucb_news) 11.04.2021
Instagram Feed
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
